Logos
Venture capitalActively deployingSan Francisco · 10 people tracked
Investment thesis
Logos Capital believes biotechnology success requires a holistic approach integrating clinical, operational, regulatory, and commercial expertise. The firm targets transformative therapeutics including functional cures, improved patient access, and extended life expectancy. Investment decisions are grounded in rigorous clinical underwriting, continuous event tracking, and multi-layered risk management to assess intrinsic value and align with long-term investor returns.
Source: firm website, verified Jul 21, 2026.
Team · 10 people
from the firm's websiteWhat they invest in
from 1 of 1 portfolio companiesBiotech ×1
HQs:China×1
Investments · 1 tracked
founders shown can be your intro pathNiKang Therapeutics is a clinical-stage biotech company developing small molecule drugs for cancer treatment, focusing on HIF2α, CDK2, and KRAS targets using structure-based drug design.
Biotech
Frequently asked questions
- What sectors does Logos focus on?
- Logos focuses on Biotech, Healthtech.
- Where is Logos located?
- Logos is headquartered in San Francisco, US.
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
Canaan is an early-stage venture capital firm investing in transformative entrepreneurs across healthcare, consumer technology, and deep tech sectors.